Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Peter Corry

Concepts (422)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hyperthermia, Induced
24
2012
115
1.980
Why?
Heat-Shock Proteins
11
2005
96
1.260
Why?
Radiotherapy, Intensity-Modulated
10
2017
177
1.140
Why?
Hot Temperature
27
2012
197
1.040
Why?
Radiotherapy Planning, Computer-Assisted
12
2017
253
0.980
Why?
Antioxidants
2
2020
237
0.880
Why?
Radiometry
8
2017
123
0.830
Why?
Neoplasms
19
2016
1246
0.780
Why?
Tomography, Spiral Computed
5
2017
56
0.700
Why?
Radiation-Protective Agents
3
2020
72
0.700
Why?
Abdomen
2
2011
75
0.690
Why?
Gene Expression Regulation, Neoplastic
12
2012
831
0.640
Why?
Heart
4
2013
341
0.610
Why?
Radiotherapy
4
2014
125
0.600
Why?
Oxygen
3
2012
319
0.590
Why?
Radiotherapy, Image-Guided
3
2016
23
0.560
Why?
Pneumonia, Viral
1
2020
169
0.540
Why?
Radiation Injuries, Experimental
6
2013
80
0.540
Why?
Coronavirus Infections
1
2020
176
0.530
Why?
Organ Sparing Treatments
3
2016
56
0.520
Why?
Pandemics
1
2020
553
0.490
Why?
Mammary Neoplasms, Experimental
3
2012
121
0.470
Why?
Animals
47
2021
13062
0.460
Why?
Radiosurgery
2
2016
123
0.460
Why?
Cell Survival
22
2012
587
0.440
Why?
Organs at Risk
3
2016
71
0.430
Why?
Head and Neck Neoplasms
3
2017
288
0.420
Why?
Tumor Cells, Cultured
22
2001
453
0.410
Why?
Radiotherapy Dosage
13
2017
248
0.410
Why?
Peptides
3
2012
218
0.400
Why?
HSP70 Heat-Shock Proteins
5
1995
60
0.400
Why?
Radiation Injuries
3
2013
112
0.400
Why?
Isoquinolines
5
1996
28
0.390
Why?
Ultrasonic Therapy
5
2008
34
0.390
Why?
Galectin 1
1
2012
20
0.390
Why?
Blood Vessels
1
2012
71
0.380
Why?
Protein Kinase C
7
1996
71
0.370
Why?
Brain Neoplasms
2
2012
281
0.360
Why?
Molecular Targeted Therapy
1
2012
122
0.360
Why?
Piperazines
5
1996
120
0.360
Why?
Bone and Bones
2
2011
481
0.350
Why?
Myocardium
4
2014
443
0.340
Why?
Prostatic Neoplasms
6
2017
386
0.340
Why?
Acetylcysteine
2
2010
101
0.330
Why?
Carcinoma, Squamous Cell
2
2012
326
0.330
Why?
Fibroblast Growth Factor 2
4
1999
35
0.330
Why?
Sulfonamides
3
1995
125
0.320
Why?
Mice
13
2021
5658
0.320
Why?
Bone Density
1
2011
386
0.310
Why?
Image Processing, Computer-Assisted
3
2017
245
0.310
Why?
Cranial Irradiation
2
2009
18
0.310
Why?
Cerebellar Neoplasms
2
2009
21
0.310
Why?
Combined Modality Therapy
10
2012
640
0.310
Why?
Heat-Shock Response
2
2005
25
0.290
Why?
Medulloblastoma
1
2008
17
0.290
Why?
Oxygen Consumption
1
2009
191
0.290
Why?
Humans
59
2021
50417
0.290
Why?
Sodium Compounds
4
1994
11
0.280
Why?
Arsenites
4
1994
13
0.280
Why?
Arsenic
3
1991
22
0.270
Why?
Whole-Body Irradiation
3
2020
131
0.270
Why?
Cell Hypoxia
2
2012
82
0.260
Why?
Radiobiology
1
2005
21
0.250
Why?
Breast Neoplasms
9
2016
1198
0.250
Why?
Medicine
1
2005
58
0.240
Why?
Rats
17
2021
3262
0.230
Why?
Radiation Dosage
7
2008
162
0.230
Why?
Dose-Response Relationship, Radiation
8
2012
183
0.230
Why?
Brain
1
2012
1318
0.220
Why?
Quercetin
2
1994
15
0.210
Why?
Signal Transduction
5
2013
1608
0.210
Why?
Brachytherapy
7
1998
46
0.210
Why?
Promoter Regions, Genetic
4
2001
455
0.210
Why?
Tocotrienols
2
2013
37
0.210
Why?
Radiotherapy, Conformal
2
2016
53
0.200
Why?
Radiation Tolerance
7
2013
84
0.200
Why?
Neovascularization, Pathologic
3
2012
155
0.200
Why?
Mitogen-Activated Protein Kinases
2
2000
154
0.200
Why?
Transcription Factor AP-1
3
1999
61
0.190
Why?
Paclitaxel
2
2009
84
0.190
Why?
Glucose
4
2000
340
0.190
Why?
Cell Line
12
2005
997
0.190
Why?
Gene Expression
5
2012
605
0.190
Why?
Drug Resistance, Multiple
6
2000
24
0.180
Why?
High-Intensity Focused Ultrasound Ablation
2
2011
14
0.180
Why?
Cricetinae
14
2021
207
0.180
Why?
Cell Nucleus
4
1991
183
0.180
Why?
Cycloheximide
6
1994
36
0.180
Why?
Lung Neoplasms
3
2017
597
0.180
Why?
Angiogenesis Inhibitors
2
2012
183
0.170
Why?
Models, Biological
3
2016
717
0.160
Why?
Crystallins
2
1996
11
0.160
Why?
Carcinoma
4
1999
137
0.160
Why?
Temperature
7
2005
157
0.150
Why?
Male
21
2021
25867
0.150
Why?
MicroRNAs
1
2021
345
0.140
Why?
Tomography, X-Ray Computed
4
2016
1163
0.140
Why?
Colonic Neoplasms
8
1995
155
0.140
Why?
Enzyme Inhibitors
3
1996
369
0.140
Why?
Radiation-Sensitizing Agents
2
2010
51
0.140
Why?
Genes, bcl-2
1
1997
5
0.140
Why?
Rectum
4
1998
52
0.130
Why?
RNA, Messenger
7
1999
1085
0.130
Why?
Genes, myc
1
1997
33
0.130
Why?
Esophageal Neoplasms
1
1998
105
0.130
Why?
Kinetics
7
1996
634
0.130
Why?
Calcitriol
1
1996
41
0.130
Why?
Base Sequence
7
1996
622
0.130
Why?
Time Factors
10
2014
2933
0.130
Why?
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
5
1996
7
0.130
Why?
Molecular Sequence Data
7
1996
760
0.130
Why?
Radiation Protection
2
2016
47
0.130
Why?
Cell Line, Tumor
4
2012
1392
0.120
Why?
Mice, Inbred C57BL
2
2011
1796
0.120
Why?
Fourier Analysis
1
1995
18
0.120
Why?
DNA-Binding Proteins
3
1994
410
0.120
Why?
Craniospinal Irradiation
1
2014
9
0.120
Why?
Radiation Pneumonitis
2
2016
9
0.110
Why?
Equipment Design
2
2012
290
0.110
Why?
Apoptosis
2
2014
1092
0.110
Why?
Membrane Proteins
1
1996
337
0.110
Why?
Harringtonines
1
1993
3
0.110
Why?
Phantoms, Imaging
3
2011
121
0.110
Why?
Carcinoma, Non-Small-Cell Lung
1
2016
153
0.110
Why?
Immunohistochemistry
2
2013
955
0.110
Why?
Pentoxifylline
1
2013
12
0.110
Why?
Transcription Factors
2
1994
561
0.110
Why?
Antineoplastic Agents, Phytogenic
1
1993
66
0.110
Why?
Phosphorylation
4
2013
520
0.110
Why?
Monte Carlo Method
1
2013
85
0.100
Why?
Oxidative Stress
4
2012
770
0.100
Why?
Female
25
2021
27053
0.100
Why?
Kininogens
1
2012
3
0.100
Why?
Kallikrein-Kinin System
1
2012
3
0.100
Why?
Ablation Techniques
1
2012
21
0.100
Why?
Deuterium
1
1992
45
0.100
Why?
Tumor Burden
2
2010
130
0.100
Why?
Cisplatin
4
2009
283
0.100
Why?
Computer Simulation
5
2016
273
0.100
Why?
Leukemia, Myeloid, Acute
2
2011
180
0.100
Why?
Bystander Effect
1
2012
25
0.100
Why?
Carrier Proteins
1
1993
297
0.100
Why?
Mitogen-Activated Protein Kinase 1
4
2013
50
0.100
Why?
Oligodeoxyribonucleotides
4
1996
33
0.100
Why?
Adaptation, Physiological
1
1992
91
0.100
Why?
Models, Chemical
2
2008
64
0.090
Why?
Myocarditis
1
2012
46
0.090
Why?
Adenoviridae
3
2001
47
0.090
Why?
Acclimatization
1
1991
17
0.090
Why?
Models, Theoretical
1
2012
168
0.090
Why?
Organ Specificity
1
2011
109
0.090
Why?
Transcription, Genetic
3
1999
354
0.090
Why?
Cell Proliferation
2
2012
980
0.090
Why?
Genetic Vectors
3
2001
128
0.090
Why?
Nuclear Proteins
1
1992
235
0.090
Why?
Neoplasm Proteins
1
1993
320
0.090
Why?
Transfection
4
2000
353
0.090
Why?
Mitochondria
1
2014
400
0.090
Why?
Radiography
2
2009
482
0.080
Why?
Leukocyte Count
1
2010
71
0.080
Why?
CHO Cells
5
1992
117
0.080
Why?
Cytokines
1
1993
602
0.080
Why?
Drug Resistance, Neoplasm
3
1997
315
0.080
Why?
Middle Aged
9
2021
12579
0.080
Why?
Genes, jun
3
1999
21
0.080
Why?
Genes, fos
3
1999
28
0.080
Why?
Taxoids
1
2009
37
0.080
Why?
Carboplatin
1
2009
54
0.080
Why?
Fluorouracil
1
2009
59
0.080
Why?
Body Weight
1
2011
517
0.080
Why?
Disease Progression
1
2012
825
0.080
Why?
Information Systems
1
1989
27
0.080
Why?
Follow-Up Studies
3
2009
2231
0.080
Why?
Nucleoside Deaminases
2
1999
3
0.080
Why?
Spinal Neoplasms
1
2009
29
0.080
Why?
Cell Death
3
2005
175
0.080
Why?
Necrosis
1
2009
173
0.080
Why?
Thymidine Kinase
2
1999
18
0.080
Why?
Aged
6
2021
9738
0.080
Why?
Osteogenesis
1
2011
354
0.080
Why?
History, 20th Century
1
2009
100
0.080
Why?
Microscopy, Fluorescence
1
2009
161
0.080
Why?
Bone Marrow
2
2010
360
0.080
Why?
Gene Expression Regulation
3
2021
948
0.080
Why?
Carbon
1
2008
54
0.070
Why?
Reactive Oxygen Species
1
2010
408
0.070
Why?
Protein Biosynthesis
1
1990
231
0.070
Why?
Weight Loss
1
2010
245
0.070
Why?
Genetic Therapy
2
1999
120
0.070
Why?
Radiotherapy, Computer-Assisted
1
2007
16
0.070
Why?
Skull
1
2007
77
0.070
Why?
Adult
8
2021
13561
0.070
Why?
Dose-Response Relationship, Drug
4
1995
1369
0.070
Why?
Central Nervous System Neoplasms
1
2007
61
0.070
Why?
Spine
1
2007
90
0.070
Why?
Ovary
6
1990
114
0.070
Why?
3T3 Cells
3
1996
56
0.060
Why?
Particle Accelerators
2
2017
51
0.060
Why?
Antineoplastic Agents
2
1993
1165
0.060
Why?
Rats, Sprague-Dawley
3
2014
1556
0.060
Why?
Swine
3
2012
408
0.060
Why?
DNA Damage
4
2012
299
0.060
Why?
Blotting, Northern
3
1996
109
0.060
Why?
DNA Repair
4
1988
187
0.060
Why?
DNA, Neoplasm
2
1993
144
0.060
Why?
Retrospective Studies
3
2012
6274
0.060
Why?
Antiviral Agents
3
2021
171
0.060
Why?
Aged, 80 and over
3
2021
3233
0.060
Why?
Treatment Outcome
2
2012
5265
0.060
Why?
Cytomegalovirus
2
2001
28
0.050
Why?
Hydrogen-Ion Concentration
3
1994
167
0.050
Why?
Diathermy
1
1983
1
0.050
Why?
Recombinant Proteins
3
2000
477
0.050
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2009
997
0.050
Why?
Cricetulus
8
1990
106
0.050
Why?
Magnetics
1
1983
35
0.050
Why?
X-Rays
4
2016
55
0.050
Why?
Mitogen-Activated Protein Kinase 3
2
2013
49
0.050
Why?
JNK Mitogen-Activated Protein Kinases
2
2000
71
0.050
Why?
Antigens, Differentiation, Myelomonocytic
2
2013
39
0.050
Why?
Genes, Recessive
1
2002
15
0.050
Why?
Genetic Heterogeneity
1
2002
17
0.050
Why?
Flucytosine
2
1999
14
0.050
Why?
Antimetabolites
2
1999
13
0.050
Why?
Ganciclovir
2
1999
25
0.050
Why?
Genetic Markers
1
2002
104
0.050
Why?
Sensitivity and Specificity
3
2009
855
0.050
Why?
Microcephaly
1
2002
39
0.050
Why?
Ultrasonics
1
1982
29
0.050
Why?
Ferrets
1
2021
6
0.050
Why?
Antigens, CD
2
2013
221
0.050
Why?
Leucine
2
1994
118
0.050
Why?
Genetic Variation
1
2002
197
0.050
Why?
Glycolysis
1
2021
69
0.050
Why?
Transgenes
1
2001
50
0.040
Why?
ROC Curve
1
2021
223
0.040
Why?
Genes, Reporter
1
2001
87
0.040
Why?
Luminescent Proteins
1
2001
54
0.040
Why?
Recombinant Fusion Proteins
2
1999
186
0.040
Why?
Green Fluorescent Proteins
1
2001
90
0.040
Why?
Algorithms
2
2016
624
0.040
Why?
Proto-Oncogene Proteins c-fos
1
1999
61
0.040
Why?
Proto-Oncogene Proteins c-jun
1
1999
77
0.040
Why?
Prodrugs
1
1999
33
0.040
Why?
Rabbits
2
2010
369
0.040
Why?
Proteomics
1
2021
313
0.040
Why?
Linear Models
2
2016
283
0.040
Why?
Clinical Trials as Topic
2
1991
488
0.040
Why?
Blotting, Western
3
2012
575
0.040
Why?
Reproducibility of Results
3
2009
1181
0.040
Why?
Protein Kinase C-alpha
2
2013
10
0.040
Why?
Proteins
2
2010
340
0.030
Why?
Inflammation
1
2021
607
0.030
Why?
Rectal Diseases
1
1997
10
0.030
Why?
Protein Binding
2
1996
648
0.030
Why?
Glioma
3
1993
74
0.030
Why?
Cell Division
2
1996
292
0.030
Why?
Body Temperature
2
1989
67
0.030
Why?
Wound Healing
1
1998
183
0.030
Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1996
34
0.030
Why?
Cell Cycle
2
1995
227
0.030
Why?
Gene Expression Regulation, Enzymologic
1
1998
178
0.030
Why?
HSP30 Heat-Shock Proteins
1
1996
1
0.030
Why?
DNA
4
1988
534
0.030
Why?
Tetradecanoylphorbol Acetate
1
1996
47
0.030
Why?
Receptors, Calcitriol
1
1996
22
0.030
Why?
Leukemia, Myeloid
1
1996
44
0.030
Why?
Isoenzymes
1
1996
165
0.030
Why?
Cone-Beam Computed Tomography
1
2016
32
0.030
Why?
Poisson Distribution
1
2016
33
0.030
Why?
Flow Cytometry
2
1996
472
0.030
Why?
Quality Assurance, Health Care
3
1991
149
0.030
Why?
Electrophoresis, Polyacrylamide Gel
2
1996
98
0.030
Why?
Probability
1
2016
163
0.030
Why?
Adolescent
4
2009
6453
0.030
Why?
Multiple Myeloma
1
2010
2990
0.030
Why?
Hypoglycemia
1
1996
55
0.030
Why?
G2 Phase
1
1995
13
0.030
Why?
Fibrosarcoma
2
2011
12
0.030
Why?
Radio Waves
1
1995
7
0.030
Why?
Neoplasms, Experimental
2
2009
111
0.030
Why?
Mathematics
1
1995
40
0.030
Why?
Thermodynamics
1
1995
33
0.030
Why?
Radiation, Ionizing
1
1995
99
0.030
Why?
Mitosis
1
1995
87
0.030
Why?
Dimethyl Sulfoxide
1
1994
13
0.030
Why?
Mitochondrial Membrane Transport Proteins
1
2014
18
0.030
Why?
Membrane Potential, Mitochondrial
1
2014
36
0.030
Why?
Gliosarcoma
1
1994
5
0.030
Why?
Cell Respiration
1
2014
41
0.030
Why?
Enzyme Activation
3
2000
268
0.030
Why?
HSC70 Heat-Shock Proteins
1
1993
7
0.030
Why?
bcl-2-Associated X Protein
1
2014
57
0.030
Why?
Child, Preschool
3
2009
3953
0.030
Why?
Cyclic AMP-Dependent Protein Kinases
1
1994
53
0.030
Why?
Software
1
2016
268
0.030
Why?
Protein Conformation
1
2014
163
0.030
Why?
Cells, Cultured
4
1991
1564
0.030
Why?
Cell Count
1
2013
150
0.030
Why?
Mast Cells
1
2013
55
0.030
Why?
Cell Differentiation
1
1996
640
0.030
Why?
Proto-Oncogene Proteins c-bcl-2
1
2014
128
0.030
Why?
Drug Interactions
1
2013
207
0.030
Why?
Skin Temperature
1
2012
15
0.030
Why?
Multigene Family
1
1992
46
0.030
Why?
Proto-Oncogene Proteins c-akt
1
2013
155
0.030
Why?
Mitochondrial Swelling
1
2012
4
0.030
Why?
Rats, Inbred BN
1
2012
13
0.030
Why?
Receptor, Bradykinin B2
1
2012
7
0.020
Why?
Models, Animal
1
2013
225
0.020
Why?
DNA Probes
1
1992
28
0.020
Why?
Film Dosimetry
1
2012
15
0.020
Why?
Up-Regulation
1
2014
446
0.020
Why?
Administration, Oral
1
2013
438
0.020
Why?
MAP Kinase Signaling System
1
2012
117
0.020
Why?
Cell Fractionation
1
1991
17
0.020
Why?
Neck
1
2012
100
0.020
Why?
Burns
2
2012
161
0.020
Why?
Endothelial Cells
1
2013
256
0.020
Why?
Computer-Aided Design
1
2011
22
0.020
Why?
Equipment Failure Analysis
1
2011
45
0.020
Why?
Evaluation Studies as Topic
2
1988
106
0.020
Why?
Heart Ventricles
1
2013
266
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2012
568
0.020
Why?
Partial Pressure
1
2011
14
0.020
Why?
Protein Synthesis Inhibitors
1
1990
17
0.020
Why?
Bone Transplantation
1
2010
43
0.020
Why?
Child
3
2009
6931
0.020
Why?
Cell Transformation, Neoplastic
1
2011
182
0.020
Why?
Protein Transport
1
2010
183
0.020
Why?
Feasibility Studies
1
2011
389
0.020
Why?
Proliferating Cell Nuclear Antigen
1
2009
68
0.020
Why?
Filing
1
1989
1
0.020
Why?
DNA, Single-Stranded
3
1979
88
0.020
Why?
Mammary Glands, Animal
1
2009
69
0.020
Why?
Cytosine Deaminase
2
1999
7
0.020
Why?
Metaphase
1
1968
45
0.020
Why?
Chromosomes
1
1968
32
0.020
Why?
Metals
1
2008
34
0.020
Why?
Acute Disease
1
2009
374
0.020
Why?
Glutathione
2
2000
297
0.020
Why?
Lung
1
2011
493
0.020
Why?
Skin
1
2009
382
0.020
Why?
Survival Rate
1
2009
906
0.020
Why?
Kidney
1
2011
690
0.020
Why?
Rats, Wistar
2
1997
222
0.020
Why?
Severity of Illness Index
1
2009
976
0.020
Why?
Liver
1
2011
1126
0.010
Why?
Electrodes
1
1984
35
0.010
Why?
Consanguinity
1
2002
17
0.010
Why?
Microsatellite Repeats
1
2002
37
0.010
Why?
Medical Laboratory Science
1
1982
2
0.010
Why?
Cystamine
1
1982
2
0.010
Why?
Cysteamine
1
1982
7
0.010
Why?
Gases
1
1982
9
0.010
Why?
Methods
1
1981
56
0.010
Why?
Thoracic Neoplasms
1
1981
13
0.010
Why?
Abdominal Neoplasms
1
1981
15
0.010
Why?
Pelvic Neoplasms
1
1981
14
0.010
Why?
Cell Adhesion
1
1982
155
0.010
Why?
Intellectual Disability
1
2002
121
0.010
Why?
Cytarabine
1
1981
37
0.010
Why?
Clinical Protocols
2
1991
111
0.010
Why?
Mitomycins
1
1980
2
0.010
Why?
Dipeptides
1
2000
22
0.010
Why?
Cysteine
1
2000
50
0.010
Why?
Phenotype
1
2002
736
0.010
Why?
Young Adult
1
2009
4075
0.010
Why?
Bleomycin
1
1979
34
0.010
Why?
Antimetabolites, Antineoplastic
1
1999
35
0.010
Why?
Gene Expression Regulation, Viral
1
1999
47
0.010
Why?
Proto-Oncogene Proteins c-myc
1
1999
50
0.010
Why?
Doxorubicin
1
2000
235
0.010
Why?
Herpesvirus 1, Human
1
1998
15
0.010
Why?
Glutathione Disulfide
1
1998
38
0.010
Why?
Gene Transfer Techniques
1
1998
41
0.010
Why?
Iridium Radioisotopes
1
1997
3
0.010
Why?
Glutamic Acid
1
1998
109
0.010
Why?
Escherichia coli
1
1998
176
0.010
Why?
S Phase
1
1996
18
0.010
Why?
Glutamine
1
1998
175
0.010
Why?
DNA, Complementary
1
1996
134
0.010
Why?
Cytoplasm
1
1996
92
0.010
Why?
Adenocarcinoma
1
1980
396
0.010
Why?
Intestinal Obstruction
1
1996
36
0.010
Why?
Diarrhea
1
1996
91
0.010
Why?
Plasmids
1
1996
159
0.010
Why?
Infant, Newborn
1
2002
2752
0.010
Why?
Sodium Salicylate
1
1994
4
0.010
Why?
Cadmium Chloride
1
1994
3
0.010
Why?
Stimulation, Chemical
1
1994
30
0.010
Why?
Physical Stimulation
1
1994
35
0.010
Why?
Electrons
1
1974
19
0.010
Why?
Adaptation, Biological
1
1994
8
0.010
Why?
Cadmium
1
1994
21
0.010
Why?
Regulatory Sequences, Nucleic Acid
1
1994
39
0.010
Why?
Chlorides
1
1994
49
0.010
Why?
Infant
1
2002
3648
0.010
Why?
Stress, Physiological
1
1994
171
0.010
Why?
Disease Models, Animal
1
1997
1431
0.010
Why?
Equipment Safety
1
1991
12
0.010
Why?
Fibroblasts
1
1993
338
0.010
Why?
Documentation
1
1991
32
0.010
Why?
Histidinol
1
1990
1
0.010
Why?
Puromycin
1
1990
4
0.010
Why?
Electromagnetic Phenomena
1
1988
4
0.000
Why?
Drug Synergism
1
1981
149
0.000
Why?
Cross-Linking Reagents
1
1980
41
0.000
Why?
Remission, Spontaneous
1
1979
24
0.000
Why?
Creatine Kinase
1
1979
30
0.000
Why?
L-Lactate Dehydrogenase
1
1979
61
0.000
Why?
Tachycardia
1
1979
27
0.000
Why?
Etoposide
1
1979
77
0.000
Why?
Drug Therapy, Combination
1
1980
387
0.000
Why?
Peripheral Nervous System Diseases
1
1979
57
0.000
Why?
Neoplasm Metastasis
1
1979
230
0.000
Why?
Melphalan
1
1979
177
0.000
Why?
Electroencephalography
1
1979
304
0.000
Why?
Melanoma
1
1979
278
0.000
Why?
Relative Biological Effectiveness
1
1974
8
0.000
Why?
Centrifugation, Density Gradient
1
1974
23
0.000
Why?
Gamma Rays
1
1974
47
0.000
Why?
Corry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description